FERRANNINI, ELEUTERIO Statistiche
FERRANNINI, ELEUTERIO
DIP. DI MEDICINA CLINICA E SPERIMENTALE - disattivato (attivo dal 19/09/2012 al 31/12/2019)
Empagliflozin and renal sodium-hydrogen exchange in healthy subjects
2023-01-01 Biancalana, Edoardo; Rossi, Chiara; Raggi, Francesco; Distaso, Mariarosaria; Tricò, Domenico; Baldi, Simona; Ferrannini, Ele; Solini, Anna
Differential effects of bariatric surgery on plasma levels of ANGPTL3 and ANGPTL4
2022-01-01 Bini, Simone; D'Erasmo, Laura; Astiarraga, Brenno; Minicocci, Ilenia; Palumbo, Maria; Pecce, Valeria; Polito, Luca; Di Costanzo, Alessia; Haeusler, Rebecca A; Arca, Marcello; Ferrannini, Ele; Camastra, Stefania
Differential Proteomics of Cardiovascular Risk and Coronary Artery Disease in Humans
2022-01-01 Ferrannini, Eleuterio; Manca, MARIA LAURA; Ferrannini, Giulia; Andreotti, Felicita; Andreini, Daniele; Latini, Roberto; Magnoni, Marco; Williams, Stephen A.; Maseri, Attilio; Maggioni, Aldo P.
Effect of empagliflozin on plasma proprotein convertase subtilisin/kexin type 9 (PCSK9) in patients with type 2 diabetes
2022-01-01 Tricò, Domenico; Raggi, Francesco; Distaso, Mariarosaria; Ferrannini, Ele; Solini, Anna
Hepatic FoxOs link insulin signaling with plasma lipoprotein metabolism through an apolipoprotein M/sphingosine-1-phosphate pathway
2022-01-01 Izquierdo, M. C.; Shanmugarajah, N.; Lee, S. X.; Kraakman, M. J.; Westerterp, M.; Kitamoto, T.; Harris, M.; Cook, J. R.; Gusarova, G. A.; Zhong, K.; Marbuary, E.; O-Sullivan, I.; Rasmus, N.; Camastra, S.; Unterman, T. G.; Ferrannini, E.; Hurwitz, B. E.; Haeusler, R. A.
Role of anatomical location, cellular phenotype and perfusion of adipose tissue in intermediary metabolism: A narrative review
2022-01-01 Camastra, S.; Ferrannini, E.
Different mechanisms of GIP and GLP-1 action explain their different therapeutic efficacy in type 2 diabetes
2021-01-01 Grespan, E.; Giorgino, T.; Natali, A.; Ferrannini, E.; Mari, A.
Differential metabolomic signatures of declining renal function in Types 1 and 2 diabetes
2021-01-01 Manca, Maria Laura; Solini, Anna; Haukka, Jani K; Sandholm, Niina; Forsblom, Carol; Groop, Per-Henrik; Ferrannini, Ele
Effects of GLP-1 receptor agonists and SGLT-2 inhibitors on cardiac structure and function: a narrative review of clinical evidence
2021-01-01 Natali, A.; Nesti, L.; Trico, D.; Ferrannini, E.
HDL Containing Apolipoprotein C-III is Associated with Insulin Sensitivity: A Multicenter Cohort Study
2021-01-01 Yamamoto, R.; Jensen, M. K.; Aroner, S.; Furtado, J. D.; Rosner, B.; Hu, F. B.; Balkau, B.; Natali, A.; Ferrannini, E.; Baldi, S.; Sacks, F. M.
New Insights on the Interactions Between Insulin Clearance and the Main Glucose Homeostasis Mechanisms
2021-01-01 Bizzotto, Roberto; Tricò, Domenico; Natali, Andrea; Gastaldelli, Amalia; Muscelli, Elza; De Fronzo, Ralph A; Arslanian, Silva; Ferrannini, Ele; Mari, Andrea
Predictors of type 2 diabetes relapse after Roux-en-Y Gastric Bypass: a ten-year follow-up study
2021-01-01 Moriconi, Diego; Manca, Maria Laura; Anselmino, Marco; Rebelos, Eleni; Bellini, Rosario; Taddei, Stefano; Ferrannini, Ele; Nannipieri, Monica
Comparison of paracetamol absorption and gastric emptying measured by scintigraphy in relation to rate of appearance of oral glucose and postprandial glycaemia
2020-01-01 Bizzotto, R; Rayner, Ck; Watson, Le; Phillips, Lk; Lange, K; Bound, Mj; Grivell, J; Wu, T; Jones, Kl; Horowitz, M; Ferrannini, E; Trico, D; Frascerra, S; Natali, A; Mari, A
Coronary Artery Disease and Type 2 Diabetes: A Proteomic Study
2020-01-01 Ferrannini, G.; Manca, M. L.; Magnoni, M.; Andreotti, F.; Andreini, D.; Latini, R.; Maseri, A.; Maggioni, A. P.; Ostroff, R. M.; Williams, S. A.; Ferrannini, E.
Differential Impact of Weight Loss and Glycemic Control on Inflammasome Signaling
2020-01-01 Antonioli, L.; Moriconi, D.; Masi, S.; Bottazzo, D.; Pellegrini, C.; Fornai, M.; Anselmino, M.; Ferrannini, E.; Blandizzi, C.; Taddei, S.; Nannipieri, M.
Effects of Sustained Treatment With Lixisenatide on Gastric Emptying and Postprandial Glucose Metabolism in Type 2 Diabetes: A Randomized Controlled Trial
2020-01-01 Rayner, Christopher K; Watson, Linda E; Phillips, Liza K; Lange, Kylie; Bound, Michelle J; Grivell, Jacqueline; Wu, Tongzhi; Jones, Karen L; Horowitz, Michael; Ferrannini, Ele; Tricò, Domenico; Frascerra, Silvia; Mari, Andrea; Natali, Andrea
Erratum. Effects of Sustained Treatment With Lixisenatide on Gastric Emptying and Postprandial Glucose Metabolism in Type 2 Diabetes: A Randomized Controlled Trial. Diabetes Care 2020;43:1813-1821
2020-01-01 Rayner, Christopher K; Watson, Linda E; Phillips, Liza K; Lange, Kylie; Bound, Michelle J; Grivell, Jacqueline; Wu, Tongzhi; Jones, Karen L; Horowitz, Michael; Ferrannini, Ele; Tricò, Domenico; Frascerra, Silvia; Mari, Andrea; Natali, Andrea
Impact of Postprandial Hypoglycemia on Weight Loss After Bariatric Surgery.
2020-01-01 Rebelos, E; Moriconi, D; Scalese, M; Denoth, F; Molinaro, S; Siciliano, V; Anselmino, M; Taddei, S; Ferrannini, E; Nannipieri, M.
Plasma N-Acetylaspartate Is Related to Age, Obesity, and Glucose Metabolism: Effects of Antidiabetic Treatment and Bariatric Surgery
2020-01-01 Daniele, Giuseppe; Campi, Beatrice; Saba, Alessandro; Codini, Simone; Ciccarone, Annamaria; Giusti, Laura; Del Prato, Stefano; Esterline, Russel L.; Ferrannini, Ele
Plasma N-acetylaspartate: development and validation of a quantitative assay based on HPLC-MS-MS and sample derivatization
2020-01-01 Campi, Beatrice; Codini, Simone; Daniele, Giuseppe; Marvelli, Antonella; Ceccarini, Giovanni; Santini, Ferruccio; Zucchi, Riccardo; Ferrannini, Ele; Saba, Alessandro
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Empagliflozin and renal sodium-hydrogen exchange in healthy subjects | 1-gen-2023 | Biancalana, Edoardo; Rossi, Chiara; Raggi, Francesco; Distaso, Mariarosaria; Tricò, Domenico; Baldi, Simona; Ferrannini, Ele; Solini, Anna | |
| Differential effects of bariatric surgery on plasma levels of ANGPTL3 and ANGPTL4 | 1-gen-2022 | Bini, Simone; D'Erasmo, Laura; Astiarraga, Brenno; Minicocci, Ilenia; Palumbo, Maria; Pecce, Valeria; Polito, Luca; Di Costanzo, Alessia; Haeusler, Rebecca A; Arca, Marcello; Ferrannini, Ele; Camastra, Stefania | |
| Differential Proteomics of Cardiovascular Risk and Coronary Artery Disease in Humans | 1-gen-2022 | Ferrannini, Eleuterio; Manca, MARIA LAURA; Ferrannini, Giulia; Andreotti, Felicita; Andreini, Daniele; Latini, Roberto; Magnoni, Marco; Williams, Stephen A.; Maseri, Attilio; Maggioni, Aldo P. | |
| Effect of empagliflozin on plasma proprotein convertase subtilisin/kexin type 9 (PCSK9) in patients with type 2 diabetes | 1-gen-2022 | Tricò, Domenico; Raggi, Francesco; Distaso, Mariarosaria; Ferrannini, Ele; Solini, Anna | |
| Hepatic FoxOs link insulin signaling with plasma lipoprotein metabolism through an apolipoprotein M/sphingosine-1-phosphate pathway | 1-gen-2022 | Izquierdo, M. C.; Shanmugarajah, N.; Lee, S. X.; Kraakman, M. J.; Westerterp, M.; Kitamoto, T.; Harris, M.; Cook, J. R.; Gusarova, G. A.; Zhong, K.; Marbuary, E.; O-Sullivan, I.; Rasmus, N.; Camastra, S.; Unterman, T. G.; Ferrannini, E.; Hurwitz, B. E.; Haeusler, R. A. | |
| Role of anatomical location, cellular phenotype and perfusion of adipose tissue in intermediary metabolism: A narrative review | 1-gen-2022 | Camastra, S.; Ferrannini, E. | |
| Different mechanisms of GIP and GLP-1 action explain their different therapeutic efficacy in type 2 diabetes | 1-gen-2021 | Grespan, E.; Giorgino, T.; Natali, A.; Ferrannini, E.; Mari, A. | |
| Differential metabolomic signatures of declining renal function in Types 1 and 2 diabetes | 1-gen-2021 | Manca, Maria Laura; Solini, Anna; Haukka, Jani K; Sandholm, Niina; Forsblom, Carol; Groop, Per-Henrik; Ferrannini, Ele | |
| Effects of GLP-1 receptor agonists and SGLT-2 inhibitors on cardiac structure and function: a narrative review of clinical evidence | 1-gen-2021 | Natali, A.; Nesti, L.; Trico, D.; Ferrannini, E. | |
| HDL Containing Apolipoprotein C-III is Associated with Insulin Sensitivity: A Multicenter Cohort Study | 1-gen-2021 | Yamamoto, R.; Jensen, M. K.; Aroner, S.; Furtado, J. D.; Rosner, B.; Hu, F. B.; Balkau, B.; Natali, A.; Ferrannini, E.; Baldi, S.; Sacks, F. M. | |
| New Insights on the Interactions Between Insulin Clearance and the Main Glucose Homeostasis Mechanisms | 1-gen-2021 | Bizzotto, Roberto; Tricò, Domenico; Natali, Andrea; Gastaldelli, Amalia; Muscelli, Elza; De Fronzo, Ralph A; Arslanian, Silva; Ferrannini, Ele; Mari, Andrea | |
| Predictors of type 2 diabetes relapse after Roux-en-Y Gastric Bypass: a ten-year follow-up study | 1-gen-2021 | Moriconi, Diego; Manca, Maria Laura; Anselmino, Marco; Rebelos, Eleni; Bellini, Rosario; Taddei, Stefano; Ferrannini, Ele; Nannipieri, Monica | |
| Comparison of paracetamol absorption and gastric emptying measured by scintigraphy in relation to rate of appearance of oral glucose and postprandial glycaemia | 1-gen-2020 | Bizzotto, R; Rayner, Ck; Watson, Le; Phillips, Lk; Lange, K; Bound, Mj; Grivell, J; Wu, T; Jones, Kl; Horowitz, M; Ferrannini, E; Trico, D; Frascerra, S; Natali, A; Mari, A | |
| Coronary Artery Disease and Type 2 Diabetes: A Proteomic Study | 1-gen-2020 | Ferrannini, G.; Manca, M. L.; Magnoni, M.; Andreotti, F.; Andreini, D.; Latini, R.; Maseri, A.; Maggioni, A. P.; Ostroff, R. M.; Williams, S. A.; Ferrannini, E. | |
| Differential Impact of Weight Loss and Glycemic Control on Inflammasome Signaling | 1-gen-2020 | Antonioli, L.; Moriconi, D.; Masi, S.; Bottazzo, D.; Pellegrini, C.; Fornai, M.; Anselmino, M.; Ferrannini, E.; Blandizzi, C.; Taddei, S.; Nannipieri, M. | |
| Effects of Sustained Treatment With Lixisenatide on Gastric Emptying and Postprandial Glucose Metabolism in Type 2 Diabetes: A Randomized Controlled Trial | 1-gen-2020 | Rayner, Christopher K; Watson, Linda E; Phillips, Liza K; Lange, Kylie; Bound, Michelle J; Grivell, Jacqueline; Wu, Tongzhi; Jones, Karen L; Horowitz, Michael; Ferrannini, Ele; Tricò, Domenico; Frascerra, Silvia; Mari, Andrea; Natali, Andrea | |
| Erratum. Effects of Sustained Treatment With Lixisenatide on Gastric Emptying and Postprandial Glucose Metabolism in Type 2 Diabetes: A Randomized Controlled Trial. Diabetes Care 2020;43:1813-1821 | 1-gen-2020 | Rayner, Christopher K; Watson, Linda E; Phillips, Liza K; Lange, Kylie; Bound, Michelle J; Grivell, Jacqueline; Wu, Tongzhi; Jones, Karen L; Horowitz, Michael; Ferrannini, Ele; Tricò, Domenico; Frascerra, Silvia; Mari, Andrea; Natali, Andrea | |
| Impact of Postprandial Hypoglycemia on Weight Loss After Bariatric Surgery. | 1-gen-2020 | Rebelos, E; Moriconi, D; Scalese, M; Denoth, F; Molinaro, S; Siciliano, V; Anselmino, M; Taddei, S; Ferrannini, E; Nannipieri, M. | |
| Plasma N-Acetylaspartate Is Related to Age, Obesity, and Glucose Metabolism: Effects of Antidiabetic Treatment and Bariatric Surgery | 1-gen-2020 | Daniele, Giuseppe; Campi, Beatrice; Saba, Alessandro; Codini, Simone; Ciccarone, Annamaria; Giusti, Laura; Del Prato, Stefano; Esterline, Russel L.; Ferrannini, Ele | |
| Plasma N-acetylaspartate: development and validation of a quantitative assay based on HPLC-MS-MS and sample derivatization | 1-gen-2020 | Campi, Beatrice; Codini, Simone; Daniele, Giuseppe; Marvelli, Antonella; Ceccarini, Giovanni; Santini, Ferruccio; Zucchi, Riccardo; Ferrannini, Ele; Saba, Alessandro |